Business Context and Reporting Period
This Form 8-K Current Report was filed by Spero Therapeutics, Inc. on April 16, 2020. The report discloses corporate governance changes, specifically the appointment of a new director and an increase in the size of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased its size from seven to eight members.
- New Director Appointment: Scott Jackson was appointed to the Board, effective April 16, 2020.
- Director Classification: Mr. Jackson serves as a Class I Director, with his term up for reelection at the 2021 annual meeting of stockholders.
Management Commentary and Governance Details
The Board determined that Mr. Jackson is an independent director pursuant to Nasdaq listing standards. He brings over thirty years of corporate leadership experience in the pharmaceutical and biotechnology industry, including prior roles as CEO of Celator Pharmaceuticals and various positions at Eli Lilly, SmithKline Beecham, and Johnson & Johnson. He currently serves on the boards of MacroGenics, Inc. and GlycoMimetics, Inc.
Mr. Jackson will receive standard non-employee director compensation, pro-rated for the remainder of the year, and will enter into a standard indemnification agreement. No specific committee assignments have been determined at this time.
Investor Verification Checklist
- Verify the pro-rated compensation amount for Mr. Jackson in the Company's Non-Employee Director Compensation Policy (referenced in the 2020 Form 10-K).
- Confirm the specific Board committee assignments for Mr. Jackson once determined by the Board.
- Review the press release attached as Exhibit 99.1 for additional context on the appointment.
- Monitor future filings for the impact of the expanded Board on corporate governance and strategic direction.